Delivery Order SPE2DB22D1052-SPE2DB26FU7UT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Esbriet 801 mg tablets (90-count units) with a contract ceiling value of $3,425.95. This non-set-aside, competitively awarded delivery order carries firm fixed pricing and is scheduled for completion by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Esbriet 801 mg tablets (90-count) with a completion date of October 6, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $3,425.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Esbriet 801 mg tablets (90-count units) on August 18, 2025, with completion targeted for September 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion...
- The Defense Logistics Agency awarded a delivery order valued at $3,425.95 to AmerisourceBergen Drug Corp for the supply of Esbriet (pirfenidone) 801 mg tablets in a quantity of 90 units. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 17, 2025, with performance at AmerisourceBergen's corporate office facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Esbriet 801 mg tablets (90-count) valued at $3,425.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 6, 2025, with fulfillment at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's ability to compete in the open...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,425.95 for 90 tablets of Esbriet 801 mg, with a completion date of June 24, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esbriet 801 mg tablets (90-count packages) under a firm fixed-price contract valued at $3,425.95. The contract, awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,425.95 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Esbriet 267 mg tablets (270-count). The contract carries a firm fixed price and is scheduled for completion by October 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award was competitively awarded with no set-aside designation, consistent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Esbriet 267 mg tablets (270 count) under a firm fixed price contract valued at $6,851.90. The delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for 270 tablets of Esbriet 267 mg on September 23, 2025, with a ceiling value of $6,851.90 and an ultimate completion date of October 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB26FU7UTDelivery Order
The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Esbriet 267 mg tablets (270 count) with a ceiling value of $6,851.90 and completion deadline of November 6, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive procurement vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems, the Defense Health Agency, and the U.S. Coast Guard. The award reflects the contractor's demonstrated capability to meet federal requirements through open competition, with no set-aside designation applied. This particular delivery order for Esbriet, a specialized pharmaceutical product, is representative of AmerisourceBergen's extensive portfolio of federal medical supply deliveries executed under firm fixed-price contracts with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 10/16/25 |